SCHEMBL6944180

SCHEMBL6944180

CCCC(=O)c1ccc(F)cc1F

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.57
CES1 P23141 3/20 0.57
ACKR3 P25106 9/20 0.55
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
RECQL P46063 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
HTR7 P34969 1/20 0.44
GABRA1 P14867 1/20 0.44
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
GABRA2 P47869 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29746067 0.85 CES2 (0.61) CES2CES1ACKR3
SCHEMBL196379 0.85 CES2 (0.61) CES2CES1ACKR3
SCHEMBL29688370 0.84 MEN1 (0.49) ACKR3ALDH1A1HPGDALOX15TSHR
SCHEMBL176969 0.84 HTT (0.54) ALDH1A1HPGDALOX15TSHRRECQL
SCHEMBL21482768 0.84 HTR7 (0.47) CES2CES1ACKR3ALDH1A1HPGD
SCHEMBL20134974 0.84 MEN1 (0.49) ACKR3ALDH1A1HPGDALOX15TSHR
SCHEMBL21780538 0.82 F2R (0.56) CES2CES1ACKR3ALDH1A1HPGD
SCHEMBL11900526 0.82 DGAT1 (0.56) ACKR3ALDH1A1HPGDALOX15TSHR
SCHEMBL8967743 0.82 HPGD (0.46) CES2CES1ALDH1A1HPGDALOX15
SCHEMBL11847285 0.81 CES2 (0.57) CES2CES1ACKR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018109271-A1 NEW BROMODOMAIN INHIBITORS ORION CORPORATION (FI) 2018-06-21 WO disclosed
EP-0927719-B1 Triazole derivative or salt thereof, preparation process thereof as well as pharmaceutical containing said compound SSP CO LTD (JP) 2003-07-23 EP disclosed
US-6204415-B1 2,2-DIFLUORO-2-ETHYLTHIOACETOPHENONE DERIVATIVES OF GIVEN FORMULA WHICH HAVE USE AS INTERMEDIATES TO ANTIMYCOTIC AGENTS SSP CO., LTD. (JP) 2001-03-20 US disclosed
US-6194592-B1 AS ANTIMYCOTIC AGENT SSP CO., LTD. (JP) 2001-02-27 US disclosed
US-6083968-A A FUNGICIDE; 1,1-DIFLUORO-1-ETHYL THIENYL OR ETHYL THIENYL OXIDES-2-(2,4-SUBSTITUTED PHENYL)-3-(1H-1,2,4-TRIA ZOL-1-YL)-2-OXY OR HYDROXY COMPOUND SSP CO., LTD. (JP) 2000-07-04 US disclosed
EP-0927719-A1 Triazole derivative or salt thereof, preparation process thereof as well as pharmaceutical containing said compound SSP Co., Ltd. (JP) 1999-07-07 EP disclosed
EP-0047923-B1 ISOQUINOLINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1984-05-09 EP disclosed